1. Cancer facts and figures [Internet]. American Cancer Society Cited 2008. Available from:
www.cancer.org.
2. Muller A, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005;84:1–12PMID : 15480663.
4. The international Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictvie model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987–994PMID : 8141877.
5. Ko YJ, Kim CW, Park CS, et al. Classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998;83:806–812PMID : 9708949.
6. Mok TS, Steinberg J, Chan AT, et al. Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma. Cancer 1998;82:2439–2448PMID : 9635538.
7. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas: definitions, differential diagnosis, and epidemiology. Am J Srug Pathol 1996;20:103–111.
9. Rudiger T, Weisenbruger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002;13:140–149PMID : 11863096.
10. Kim HT, Im YH, Suh CI, et al. Malignant lymphomas in Korea. J Korean Cancer Assoc 1992;24:92–101.
11. Lopez-Guillermo A, Colomo L, jimenez M, et al. Diffuse lagrge B-cell lymphoma: clinical and biological characterization and outcome according to the nodal and extranodal primary origin. J Clin Oncol 2005;23:2797–2804PMID : 15728226.
12. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clincal Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69–86PMID : 10632755.
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53.
14. Mantel N. Evaluation of survival data and two new rank test order statistics arising in tis consideration. Cancer Chemother Rep 1966;50:163–170PMID : 5910392.
15. Cox D. Regression models and life-tables. J R Stat Soc 1972;34.
16. Rizvi MA, Evens AM, Tallman MS, Nelsoon BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood 2006;107:1255–1264PMID : 16210342.
17. Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol 1983;14:745–772PMID : 6350154.
18. Ho FC, Todd D, Loke SL, Ng RP, Khoo RK. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients: retrospective study covering an eight-year period. Int J Cancer 1984;34:143–148PMID : 6381328.
19. The T- and B-cell Malignancy Group. Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special reference to adutl T-cell leukemia/lymphoma: a report of the second nationwide study of Japan. Jpn J Clin Oncol 1985;15:517–535PMID : 2997510.
20. The Nationwide Lymphoma Pathology Cooperative Group (NLPCG). A retrospective histological study of 9,009 cases of malignant lymphoma in China using the NLPCG classification. Jpn J Clin Oncol 1985;15:645–651PMID : 4094097.
21. Aozasa K, Tsujimoto M, Sakurai M, et al. Non-Hodgkin's lymphomas in Osaka, Japan. Eur J Cancer Clin Oncol 1985;21:487–492PMID : 4007017.
22. Newton R, Ferlay J, Beral V, Devesa S. The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extranodal sites. Int J Cancer 1997;72:923–930PMID : 9378552.
23. Anderson JR, Armitage JO, Weisenbruger DD. Epidemiology of the non-Hodgkin's lymphomas: distrubtions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998;9:717–720PMID : 9739436.
24. National Cancer Center, National Cancer Registry of Korea [internet]. c2008;cited 2008 Oct 1. National Cancer center, Available from:
http://www.ncc.re.kr.
25. Kang YK, Kim BS, Kim TW, et al. Clinicopathologic characteristics of Korean non-Hodgkin's lymphomas based on REAL classification. J Korean Cancer Assoc 1999;31:641–652.
26. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinocopathologcial findings and outcome. Blood 1999;93:2697–2706PMID : 10194450.
27. Gascoyne RD, Aoun P, chhanabhai M, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999;93:3913–3921PMID : 10339500.
28. Gospodarowicz MK, Sutcliffe SB. The extranodal lymphomas. Semi Radiat Oncol 1995;5:281–300.
29. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas: part I. gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727–737PMID : 9332679.
30. Zucca E, Conconi A, Cavalli F. Treatment of extranodal lymphomas. Best pract Res Clin Haematol 2002;15:533–547PMID : 12468404.
31. Shih LY, Liang DC. Non-Hodgkin's lymphomas in Asia. Hematol Oncol Clin North Am 1991;5:983–1001PMID : 1938764.
32. Greiner TC, Medeiros LJ, Jaffe ES. Non-Hodgkin's lymphoma. Cancer 1995;75(1):Suppl. 370–380PMID : 8001008.